T. Rowe Price Associates
MXL icon

T. Rowe Price Associates’s MaxLinear MXL Stock Holding History

T. Rowe Price Associates’s Portfolio MXL Stock Details MXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.66M Buy
95,212
+16,278
+21% +$292K ﹤0.01% 1915
2025
Q4 		$1.38M Buy
78,934
+2,839
+4% +$46.2K ﹤0.01% 1940
2025
Q3 		$1.22M Buy
76,095
+1,794
+2% +$28.2K ﹤0.01% 1968
2025
Q2 		$1.06M Buy
74,301
+5,537
+8% +$63.9K ﹤0.01% 1967
2025
Q1 		$747K Buy
68,764
+8,358
+14% +$140K ﹤0.01% 2088
2024
Q4 		$1.2M Buy
60,406
+631
+1% +$10.1K ﹤0.01% 1893
2024
Q3 		$866K Sell
59,775
-238
-0.4% -$3.78K ﹤0.01% 2031
2024
Q2 		$1.21M Sell
60,013
-5,018
-8% -$98.6K ﹤0.01% 1815
2024
Q1 		$1.22M Sell
65,031
-1,693,505
-96% -$33.8M ﹤0.01% 1821
2023
Q4 		$41.8M Buy
1,758,536
+1,019,710
+138% +$20M 0.01% 758
2023
Q3 		$16.4M Sell
738,826
-210,416
-22% -$5.35M ﹤0.01% 965
2023
Q2 		$30M Sell
949,242
-2,409
-0.3% -$69.6K ﹤0.01% 834
2023
Q1 		$33.5M Buy
951,651
+1,596
+0.2% +$57.8K 0.01% 789
2022
Q4 		$32.3M Buy
950,055
+30,945
+3% +$1.05M 0.01% 783
2022
Q3 		$30M Sell
919,110
-1,469,582
-62% -$54.3M ﹤0.01% 788
2022
Q2 		$81.2M Sell
2,388,692
-144,640
-6% -$6.06M 0.01% 723
2022
Q1 		$148M Sell
2,533,332
-121,916
-5% -$7.42M 0.01% 620
2021
Q4 		$200M Sell
2,655,248
-31,064
-1% -$1.99M 0.02% 555
2021
Q3 		$132M Sell
2,686,312
-4,860
-0.2% -$235K 0.01% 678
2021
Q2 		$114M Sell
2,691,172
-143,953
-5% -$5.37M 0.01% 735
2021
Q1 		$96.6M Sell
2,835,125
-542,648
-16% -$19.4M 0.01% 789
2020
Q4 		$129M Sell
3,377,773
-394,233
-10% -$11.4M 0.01% 641
2020
Q3 		$87.7M Sell
3,772,006
-101,609
-3% -$2.51M 0.01% 696
2020
Q2 		$83.1M Sell
3,873,615
-10,731
-0.3% -$185K 0.01% 688
2020
Q1 		$45.3M Buy
3,884,346
+180,042
+5% +$3.02M 0.01% 819
2019
Q4 		$78.6M Buy
3,704,304
+22,900
+0.6% +$475K 0.01% 748
2019
Q3 		$82.4M Sell
3,681,404
-6,674
-0.2% -$148K 0.01% 683
2019
Q2 		$86.4M Buy
3,688,078
+34,198
+0.9% +$833K 0.01% 692
2019
Q1 		$93.3M Buy
3,653,880
+425,071
+13% +$9.3M 0.01% 656
2018
Q4 		$56.8M Buy
3,228,809
+71,189
+2% +$1.3M 0.01% 772
2018
Q3 		$62.8M Buy
3,157,620
+136,149
+5% +$2.48M 0.01% 827
2018
Q2 		$47.1M Buy
3,021,471
+62,671
+2% +$1.27M 0.01% 922
2018
Q1 		$67.3M Buy
2,958,800
+191,412
+7% +$4.76M 0.01% 765
2017
Q4 		$73.1M Buy
2,767,388
+263,909
+11% +$6.59M 0.01% 736
2017
Q3 		$59.5M Buy
2,503,479
+163,648
+7% +$3.94M 0.01% 784
2017
Q2 		$65.3M Buy
2,339,831
+96,597
+4% +$2.81M 0.01% 740
2017
Q1 		$62.9M Buy
2,243,234
+303,520
+16% +$7.78M 0.01% 730
2016
Q4 		$42.3M Buy
1,939,714
+515,990
+36% +$10.7M 0.01% 869
2016
Q3 		$28.9M Buy
1,423,724
+350,329
+33% +$6.88M 0.01% 1002
2016
Q2 		$19.3M Buy
1,073,395
+460
+0% +$8.54K ﹤0.01% 1113
2016
Q1 		$19.8M Sell
1,072,935
-153,175
-12% -$2.43M ﹤0.01% 1079
2015
Q4 		$18.1M Sell
1,226,110
-169,206
-12% -$2.55M ﹤0.01% 1115
2015
Q3 		$17.4M Sell
1,395,316
-90,110
-6% -$993K ﹤0.01% 1139
2015
Q2 		$18M Buy
1,485,426
+3,596
+0.2% +$36.1K ﹤0.01% 1168
2015
Q1 		$12M Buy
1,481,830
+6,700
+0.5% +$55.1K ﹤0.01% 1289
2014
Q4 		$10.9M Buy
1,475,130
+1,200
+0.1% +$8.57K ﹤0.01% 1302
2014
Q3 		$10.1M Sell
1,473,930
-140,387
-9% -$1.26M ﹤0.01% 1304
2014
Q2 		$16.3M Buy
1,614,317
+6,500
+0.4% +$59.6K ﹤0.01% 1175
2014
Q1 		$15.2M Buy
1,607,817
+17,186
+1% +$171K ﹤0.01% 1188
2013
Q4 		$16.6M Buy
1,590,631
+89,350
+6% +$769K ﹤0.01% 1145
2013
Q3 		$12.4M Buy
1,501,281
+25,401
+2% +$198K ﹤0.01% 1210
2013
Q2 		$10.3M Buy
+1,475,880
New +$9.31M ﹤0.01% 1242

Other funds holding MXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates's MXL Position: Q1 2026 in Review

T. Rowe Price Associates increased its MaxLinear (MXL) stake by 21% in Q1 2026, buying an estimated $292K and bringing the position to 95,212 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #1915.

T. Rowe Price Associates first reported a position in MXL in Q2 2013 and has held it in 52 quarters since. The position peaked at $200M in Q4 2021. 238 funds tracked by Wall St. Rank hold MXL as of Q1 2026.

  • T. Rowe Price Associates held 95,212 shares of MaxLinear worth $1.66M as of Q1 2026.
  • T. Rowe Price Associates bought 16,278 MaxLinear shares in Q1 2026, an estimated $292K.
  • MaxLinear made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1915 holding.
  • T. Rowe Price Associates first reported a position in MaxLinear in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's MaxLinear position peaked at $200M in Q4 2021.
  • 238 funds tracked by Wall St. Rank held MaxLinear as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.